Journal of Lipid Research, Vol 33, 975-984, Copyright © 1992 by Lipid Research, Inc.

ARTICLES

Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids

F Karpe, T Olivecrona, G Walldius and A Hamsten
King Gustav V Research Institute, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden.

Lipoprotein lipase (LPL) releases fatty acids from triglyceride-rich lipoproteins for use in cellular metabolic reactions. How this hydrolysis, which occurs at the vascular endothelium, is regulated is poorly understood. A fatty acid feedback system has been proposed by which accumulation of fatty acids impedes LPL-catalyzed hydrolysis and dissociates the enzyme from its endothelial binding sites. We examined this hypothesis in humans who were subjected to an oral fat tolerance test of a mixed-meal type. Plasma triglycerides, free fatty acids, and LPL activity were measured before and repeatedly during a 12-h period after intake of the fat load. Since soybean oil with a high content of linoleic fatty acid was the source of triglycerides, a distinction could be made between endogenous free fatty acids (FFA) and FFA derived directly from lipolysis of postprandial triglyceride-rich lipoproteins. Mean LPL activity was almost doubled (P less than 0.01) 6 h after intake of the oral fat load. The rise in LPL activity was accompanied by an increase of plasma triglycerides and linoleic free fatty acids (18:2 FFA), but not of total plasma FFA, which instead displayed a heterogeneous pattern with essentially unchanged mean levels. The postprandial response of LPL activity largely paralleled the postprandial responses of 18:2 FFA and triglycerides. The highest degree of parallelism was seen between postprandial 18:2 FFA and LPL activity levels. Furthermore, the integrated response (area under the curve, AUC) for plasma measurements of LPL correlated with the AUC for 18:2 FFA (r = 0.40, P less than 0.05), but not with the AUC for plasma triglycerides (r = 0.21, ns). The high degree of parallelism and significant correlation between postprandial plasma LPL activity and 18:2 FFA support the hypothesis of fatty acid control of endothelial LPL during physiological conditions in humans.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Annuzzi, C. De Natale, C. Iovine, L. Patti, L. Di Marino, S. Coppola, S. Del Prato, G. Riccardi, and A. A. Rivellese Insulin Resistance Is Independently Associated With Postprandial Alterations of Triglyceride-Rich Lipoproteins in Type 2 Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2397 - 2402. [Abstract] [Full Text] [PDF]

				C. Verseyden, S. Meijssen, and M. C. Cabezas Effects of Atorvastatin on Fasting Plasma and Marginated Apolipoproteins B48 and B100 in Large, Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5021 - 5029. [Abstract] [Full Text] [PDF]

				Y. Park, P. G Jones, and W. S Harris Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids Am. J. Clinical Nutrition, July 1, 2004; 80(1): 45 - 50. [Abstract] [Full Text] [PDF]

				C.J.M. Halkes, H. van Dijk, C. Verseyden, P.P.Th. de Jaegere, H.W.M Plokker, S. Meijssen, D.W. Erkelens, and M. C. Cabezas Gender Differences in Postprandial Ketone Bodies in Normolipidemic Subjects and in Untreated Patients With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1875 - 1880. [Abstract] [Full Text] [PDF]

				S. Meijssen, H. van Dijk, C. Verseyden, D.W. Erkelens, and M. C. Cabezas Delayed and Exaggerated Postprandial Complement Component 3 Response in Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 811 - 816. [Abstract] [Full Text] [PDF]

				C.J.M. Halkes, H. van Dijk, P.P.T. de Jaegere, H.W.M. Plokker, Y. van der Helm, D. W. Erkelens, and M. Castro Cabezas Postprandial Increase of Complement Component 3 in Normolipidemic Patients With Coronary Artery Disease: Effects of Expanded-Dose Simvastatin Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1526 - 1530. [Abstract] [Full Text] [PDF]

				R. D. Mattes Oral Exposure to Butter, but Not Fat Replacers Elevates Postprandial Triacylglycerol Concentration in Humans J. Nutr., May 1, 2001; 131(5): 1491 - 1496. [Abstract] [Full Text]

				T. R. Thomas, K. E. Horner, M. M. Langdon, J. Q. Zhang, E. S. Krul, G. Y. Sun, and R. H. Cox Effect of exercise and medium-chain fatty acids on postprandial lipemia J Appl Physiol, April 1, 2001; 90(4): 1239 - 1246. [Abstract] [Full Text] [PDF]

				T. Tholstrup, B. Sandstrom, A. Bysted, and G. Holmer Effect of 6 dietary fatty acids on the postprandial lipid profile, plasma fatty acids, lipoprotein lipase, and cholesterol ester transfer activities in healthy young men Am. J. Clinical Nutrition, February 1, 2001; 73(2): 198 - 208. [Abstract] [Full Text] [PDF]

				V. Pruneta, D. Autran, G. Ponsin, C. Marcais, L. Duvillard, B. Verges, F. Berthezene, and P. Moulin Ex Vivo Measurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity? J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 797 - 803. [Abstract] [Full Text]

				K. G Jackson, A. Zampelas, J. M. Knapper, H. M Roche, M. J Gibney, A. Kafatos, B. J Gould, J. W Wright, and C. M Williams Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications for postprandial lipemia Am. J. Clinical Nutrition, January 1, 2000; 71(1): 13 - 20. [Abstract] [Full Text] [PDF]

				M. J. A. Williams, W. H. F. Sutherland, M. P. McCormick, S. A. de Jong, R. J. Walker, and G. T. Wilkins Impaired endothelial function following a meal rich in used cooking fat J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1050 - 1055. [Abstract] [Full Text] [PDF]

				F. Karpe, T. Olivecrona, G. Olivecrona, J. S. Samra, L. K. M. Summers, S. M. Humphreys, and K. N. Frayn Lipoprotein lipase transport in plasma: role of muscle and adipose tissues in regulation of plasma lipoprotein lipase concentrations J. Lipid Res., December 1, 1998; 39(12): 2387 - 2393. [Abstract] [Full Text]

				L. G. Anderson, R. Carroll, H. S. Ewart, A. Acharya, and D. L. Severson Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E759 - E767. [Abstract] [Full Text] [PDF]

				H. Engelberg State-of the-Art Review : Endogenous Heparin Activity Deficiency and Atherosclerosis Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 83 - 93. [PDF]

				P. Tornvall, G. Olivecrona, F. Karpe, A. Hamsten, and T. Olivecrona Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1086 - 1093. [Abstract] [Full Text]

				F. Mailly, Y. Tugrul, P. W. A. Reymer, T. Bruin, M. Seed, B. F. Groenemeyer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, et al. A Common Variant in the Gene for Lipoprotein Lipase (Asp9->Asn) : Functional Implications and Prevalence in Normal and Hyperlipidemic Subjects Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 468 - 478. [Abstract] [Full Text]